Perfromance Wealth Partners’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $5.33M | Sell |
28,730
-6
| -0% | -$1.11K | 0.17% | 29 |
|
2025
Q1 | $6.02M | Sell |
28,736
-4,799
| -14% | -$1.01M | 0.22% | 26 |
|
2024
Q4 | $5.96M | Sell |
33,535
-413
| -1% | -$73.4K | 0.19% | 24 |
|
2024
Q3 | $6.7M | Sell |
33,948
-816
| -2% | -$161K | 0.23% | 25 |
|
2024
Q2 | $5.96M | Sell |
34,764
-1,505
| -4% | -$258K | 0.22% | 23 |
|
2024
Q1 | $6.6M | Sell |
36,269
-2,082
| -5% | -$379K | 0.28% | 28 |
|
2023
Q4 | $5.94M | Sell |
38,351
-7,201
| -16% | -$1.12M | 0.26% | 30 |
|
2023
Q3 | $6.79M | Sell |
45,552
-1,702
| -4% | -$254K | 0.33% | 31 |
|
2023
Q2 | $6.5M | Buy |
47,254
+413
| +0.9% | +$56.8K | 0.3% | 29 |
|
2023
Q1 | $7.47M | Sell |
46,841
-24
| -0.1% | -$3.83K | 0.38% | 25 |
|
2022
Q4 | $7.57M | Sell |
46,865
-4,258
| -8% | -$688K | 0.46% | 25 |
|
2022
Q3 | $6.86M | Sell |
51,123
-78
| -0.2% | -$10.5K | 0.4% | 27 |
|
2022
Q2 | $7.84M | Sell |
51,201
-3,039
| -6% | -$465K | 0.44% | 26 |
|
2022
Q1 | $8.79M | Buy |
54,240
+199
| +0.4% | +$32.3K | 0.38% | 27 |
|
2021
Q4 | $7.32M | Buy |
+54,041
| New | +$7.32M | 0.3% | 34 |
|